Skip to content

Anaesthesia for Mechanical Thrombectomy

Conduct of Anaesthesia During Acute Ischaemia Stroke: a Retrospective Case Series of Patients Undergoing Mechanical Thrombectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04804085
Enrollment
250
Registered
2021-03-18
Start date
2021-06-01
Completion date
2021-08-01
Last updated
2021-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Stroke, Ischemic

Keywords

Anaesthesia, Ischaemic, Mechanical, Case Series, Endovascular, Thrombectomy, Stroke

Brief summary

Title: Conduct of anaesthesia during acute ischaemic stroke: a retrospective case series of patients undergoing mechanical thrombectomy. Design: This study will be a retrospective consecutive observational case series

Detailed description

The Aim of this study is to describe the baseline characteristics, procedural and post-operative clinical characteristics of anaesthetic care delivered to consecutive adult patients who underwent mechanical thrombectomy as part of their routine clinical care between 01/01/2016 and 01/10/2020 at Nottingham University Hospitals NHS Trust (sample size approximately 250).

Interventions

None listed

Sponsors

Nottingham University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years old * Undergone mechanical thrombectomy for the management of acute ischaemia stroke between 01/01/2016-01/10/2020 at Nottingham University Hospitals NHS Trust.

Exclusion criteria

* No pre-specified

Design outcomes

Primary

MeasureTime frameDescription
Evaluating the number of patients requiring mechanical thrombectomyThrough study completion, up to 9 monthsThis retrospective study will identify the anaesthetic care delivered to a group of patients undergoing mechanical thrombectomy for the management of acute ischaemic stroke. The data collected will be from all patients that received this treatment between 01/01/2016 and 01/10/2020 at Nottingham University Hospitals NHS Trust. This data written up and of interest both to our organisation and to comparable neuroscience centres in the UK and internationally. Outcomes that will be measured in this clinical case study are highlighted below.

Secondary

MeasureTime frameDescription
Background information: Gender (male or female)Through study completion, up to 9 monthsPhysiological gender
Background information: The degree of disability/dependence after a stroke will be measured using the presenting modified Rankin ScoreThrough study completion, up to 9 months0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.
Background information: Presenting blood pressure (systolic and diastolic)Through study completion, up to 9 months
Background information: Presenting heart rate (beats per minute)Through study completion, up to 9 months
Background information: The fitness of the patient will be measured using the American Society of Anaesthetists ClassificationThrough study completion, up to 9 monthsASA I A normal healthy patient Healthy ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes
Background information: Height of the patient (m)Through study completion, up to 9 monthsBMI = Weight / (height x height)
Background information: Weight of the patient (kg)Through study completion, up to 9 monthsBMI = Weight / (height x height)
Background information: Measuring the distance from referring hospital (miles)Through study completion, up to 9 monthsHospitals included: Kings Mill Hospital, Royal Derby Hospital, Leicester, Lincoln, Boston, Burton
The patient's stroke classification will be measured using National Institute for Health Stroke ScaleThrough study completion, up to 9 months1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke
Mode of anaesthesiaThrough study completion, up to 9 monthsAwake / Sedated / Converted on-table to General Anaesthetic / GA.
To identify the anaesthetic agents usedThrough study completion, up to 9 monthsPropofol / Alfentanil / Remifentanil / Fentanyl / Midazolam
Background information: Age (>/= 18 years of age)Through study completion, up to 9 months
Intra - procedural observations: Measuring time spent with systolic blood pressure (mmHg) <10% of presenting BP (minutes)Through study completion, up to 9 months
Intra - procedural observations: Quantifying any episodes of hypoxia (SpO2 <94%)Through study completion, up to 9 months
Intra-procedural interventions: Identifying if the patient required vasopressorsThrough study completion, up to 9 monthsNone / metaraminol / ephedrine / noradrenaline
Measuring the response of treatment using the post-procedural Thrombolysis in Cerebral Infarction scaleThrough study completion, up to 9 monthsGrade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualised Grade 2B: complete filling of all of the expected vascular territory is visualised but the filling is slower than normal Grade 3: complete perfusion
To identify the level of care required immediately post procedure (Level 0,1,2,3)Through study completion, up to 9 months
Identify the duration of Intensive Care stays (days)Through study completion, up to 9 months
Identify the duration of stay in hospital (days)Through study completion, up to 9 monthsWhether in NUH or otherwise
To measure the long term outcome: National Institute for Health Stroke Scale at 24 hours post-procedureThrough study completion, up to 9 months1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke
To measure the long term outcome: Modified Rankin Score at 90 daysThrough study completion, up to 9 months0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.
To measure the long term outcome: Mortality at 90 days (survived / deceased)Through study completion, up to 9 months
To measure the long term outcome: Discharge destination (home / institution)Through study completion, up to 9 months
The level of the anaesthetist (registrar / consultant)Through study completion, up to 9 months

Contacts

Primary ContactDavid Hewson (Consultant Anaesthetist)
david.hewson@nuh.nhs.uk01159249924
Backup ContactHeather Broll (Junior Doctor)
heather.broll@nhs.net07717277759

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026